Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet’s Disease (INCYTOB)
Condition(s):Behcet’s Disease; Panuveitis; Posterior Uveitis; Retinal VasculitisLast Updated:May 17, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Behcet’s Disease; Panuveitis; Posterior Uveitis; Retinal VasculitisLast Updated:May 17, 2018Completed
Condition(s):Behcet’s UveitisLast Updated:January 3, 2020Terminated
Condition(s):Behcet Disease; FMFLast Updated:May 26, 2020Unknown status
Condition(s):Behcet’s Disease; Idiopathic Inflammatory Myopathies; IgG4-related DiseaseLast Updated:February 29, 2024Not yet recruiting
Condition(s):Behcet Disease; COVID; FMFLast Updated:May 27, 2020Unknown status
Condition(s):Fluid Loss; Symptom Complex, Triple; EmergenciesLast Updated:September 11, 2018Completed
Condition(s):Arthritis; BehcetLast Updated:October 26, 2016Completed
Condition(s):Autoimmune Connective Tissue Disorder; Immune System DiseasesLast Updated:May 12, 2017Completed
Condition(s):VasculitisLast Updated:August 2, 2018Terminated
Condition(s):Hereditary Autoinflammatory Diseases; Schnitzler Syndrome; Behcet Syndrome; PFAPA Syndrome; Still Disease; Autoinflammatory Syndrome, Unspecified; Uveitis; Scleritis; Vexas SyndromeLast Updated:February 21, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.